Search bioRxiv⌕ Search

bioRxiv · 10.1101/378034

Sympatric and allopatric evolutionary contexts shape differential immune response in Biomphalaria / Schistosoma interaction

Abstract

Selective pressures between hosts and their parasites can result in reciprocal evolution or adaptation of specific life history traits. Local adaptation of resident hosts and parasites should lead to host-parasite systems performing better in sympatry when compared to allopatry. Between-population variations in parasite infectivity/virulence and host defence/resistance, referred to as compatibility phenotype, were often the proxy used to analyse sympatric or allopatric adaptation. Nevertheless, some reported cases exist where allopatric host-parasite systems demonstrate compatibility phenotypes similar or greater than the one observed in sympatry. In these cases, the role of local adaptation is worth considering. Here, we study the interaction between Schistosoma and its vector snail Biomphalaria in which such a discrepancy in local versus foreign compatibility phenotype has been observed. Herein, we developed an integrative approach to investigate sympatric and allopatric interaction processes and link the underlying molecular mechanisms to the resulting phenotypes. Using comparative \"omics\" approaches joined to analysis of life history traits (immune cellular response, mortality, prevalence and compatibility) we tried to bridge the gap of knowledge that exists for connecting local adaptation observations to molecular phenotypes in Schistosoma/Biomphalaria interactions.\n\nWe found that despite displaying similar prevalence phenotypes, parasite infection triggered an immune suppression in snails living in sympatry, while it activated an immune response for those living in allopatry. Dual-comparative molecular analyses revealed that parasite infection causes immune suppression in sympatry. miRNAs were used to hijack the hosts immune response, allowing sympatric parasites to initiate their developmental program earlier and more efficiently.\n\nWe show that despite having similar prevalence phenotypes, sympatric and allopatric snail-Schistosoma interactions displayed a strongly different immunobiological molecular dialogue. The ability of allopatric pathogens to adapt rapidly and efficiently to new hosts could have critical consequences on disease emergence and risk of schistosomiasis outbreaks. These observations would have important consequences in term of schistosomiasis disease control.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Portet, A., Pinaud, S., Chaparro, C., Galinier, R., Charriere, G., Allienne, J.-F., Duval, D., Gourbal, B.. 2018-07-26. Sympatric and allopatric evolutionary contexts shape differential immune response in Biomphalaria / Schistosoma interaction. https://doi.org/10.1101/378034

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

CD19-CAR T-cell therapy resets the EBV+ autoreactive B cell repertoire in autoimmune disease

Epstein-Barr virus (EBV) reprograms autoreactive B cells into activated antigen-presenting cells that drive pathogenic T- and B-cell responses in autoimmune disease. Using EBV B-cell sequencing (EBV-seq), we profiled EBV+ B cells in patients treated with CD19 chimeric antigen receptor (CAR) T cells (systemic lupus, n=6; idiopathic inflammatory myopathies, n=3; systemic sclerosis, n=3) or rituximab (n=15). CAR T cells, but not rituximab, depleted EBV+ B cells, resetting the repertoire toward a naive state: predominantly IgM+ with minimal somatic hypermutation. Post-rituximab B-cells remained class-switched, hypermutated, and activated. Monoclonal antibodies cloned from EBV+ B cells lost autoreactivity after CAR T cells but not rituximab. Sustained drug-free remission occurred in 8/12 CAR-treated but 0/15 rituximab-treated patients. EBV+ B cells were predominantly Latency III and resisted anti-CD20 and anti-CD19 antibodies, yet were killed by CAR T cells and T-cell engagers. CD19-CAR T-cell therapy resets the autoreactive EBV+ B-cell repertoire, which may underlie sustained drug-free remission.

immunology↗

A minimal two-residue C-terminal truncation of AID in adult-onset hyper-IgM syndrome type 2 (HIGM2)

Activation-induced cytidine deaminase (AID), encoded by AICDA, facilitates class-switch recombination (CSR) and somatic hypermutation (SHM) in activated B cells. Loss of AID function causes hyper-IgM syndrome type 2 (HIGM2). While typically autosomal recessive, three C-terminal truncation variants have been reported to act in autosomal dominant manner. We describe a novel heterozygous AICDA nonsense variant, c.589G>T (p.G197*), that truncates the final two C-terminal residues of AID and results in adult-onset HIGM2. Single-cell sequencing of primary patient B cells revealed a complete block in CSR and a [~]10-fold reduction in SHM. AICDA mRNA expression was balanced between wild-type and variant alleles, yet AID protein abundance was reduced to [~]56% with normal subcellular localization. Remarkably, inducible germinal center (iGB) cultures restored CSR in purified naive patient B cells. CRISPR-Cas9 editing of healthy donor B cells confirmed that the iGB platform can rescue B cells harboring heterozygous, but not homozygous, AICDA variants. These results demonstrate that even a two-amino-acid truncation at the AID C-terminus is sufficient to disrupt its function and cause HIGM2.

immunology↗

Defining the Functional Consequence of the Human Ocular Microbiome

The ocular surface is one of the body's most environmentally exposed mucosal barriers, yet it is considered low biomass and harbors orders of magnitude fewer bacteria than microbe-rich sites like the gut. This has cast doubt on whether a functional core ocular microbiome exists at all. Having previously defined a protective gd T cell and IL-17 axis engaged by the murine commensal Corynebacterium mastitidis, we asked whether human-derived bacteria could do the same. Pairing sequencing and culturomics of healthy human conjunctiva from two geographically distinct cohorts, we define a stable core microbiome and identify Corynebacterium bovis as a consistent eye-resident commensal rather than a transient contaminant. In humans, C. bovis elicits a non-pathogenic response marked by IL-17 secretion by {gamma}{delta} T cells and circulating C. bovis-specific IgG, which suggests commensalism rather than pathology. Colonizing mice with human C. bovis strains from Pittsburgh or Miami reproduced this program and conferred protection against ocular infection with Staphylococcus aureus. Together, these findings identify C. bovis as a human-derived ocular commensal that can drive protective {gamma}{delta} T cell immunity, translating a mechanism previously defined only in mice into human relevance and a rational target against sight-threatening infection.

immunology↗